The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure
Key result
Antiinflammatory therapies for HF show limited success, highlighting the need for targeted treatments avoiding broad immunosuppression.
Why the study?
Despite increasing knowledge about inflammation in heart failure, the clinical success of antiinflammatory and immunomodulatory therapies remains limited.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Current antiinflammatory therapies warrant continued caution in heart failure; leaves open targeted immunomodulation avoiding nonspecific suppression.
Structured PICO
P
Population
Heart failure (HF)
I
Intervention
Antiinflammatory and immunomodulatory therapies
This review highlights the complexity of inflammation in heart failure and calls for targeted immunomodulatory therapies that avoid nonspecific immune suppression.
Cite This Study
Linthout et al. (2019) conducted a review in Heart failure. Antiinflammatory and immunomodulatory therapies was evaluated. Antiinflammatory and immunomodulatory therapies for heart failure have shown limited clinical success, highlighting the need for specific treatments that avoid nonspecific immune suppression.